These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26739900)

  • 21. [Large-cell lung carcinoma by the 2015 WHO classification: a clinicopathologic analysis of 93 cases].
    Zhang JY; Xu XY; Shen Q; Wang YF; Wang X; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2016 Apr; 45(4):231-6. PubMed ID: 27033385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is the current diagnostic algorithm reliable for selecting cases for EGFR- and KRAS-mutation analysis in lung cancer?
    Vincenten JP; Smit EF; Grünberg K; Postmus PE; Snijders PJ; Witte BI; Heideman DA; Thunnissen E
    Lung Cancer; 2015 Jul; 89(1):19-26. PubMed ID: 25982011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal combination of immunohistochemical markers for subclassification of non-small cell lung carcinomas: A tissue microarray study of poorly differentiated areas.
    Noh S; Shim H
    Lung Cancer; 2012 Apr; 76(1):51-5. PubMed ID: 21978426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ΔNp63 (p40) and thyroid transcription factor-1 immunoreactivity on small biopsies or cellblocks for typing non-small cell lung cancer: a novel two-hit, sparing-material approach.
    Pelosi G; Fabbri A; Bianchi F; Maisonneuve P; Rossi G; Barbareschi M; Graziano P; Cavazza A; Rekhtman N; Pastorino U; Scanagatta P; Papotti M
    J Thorac Oncol; 2012 Feb; 7(2):281-90. PubMed ID: 22071786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung.
    Monica V; Ceppi P; Righi L; Tavaglione V; Volante M; Pelosi G; Scagliotti GV; Papotti M
    Mod Pathol; 2009 May; 22(5):709-17. PubMed ID: 19287461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Grading of lung cancer].
    Bohle RM; Schnabel PA
    Pathologe; 2016 Jul; 37(4):314-9. PubMed ID: 27356985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TTF-1, cytokeratin 7, 34betaE12, and CD56/NCAM immunostaining in the subclassification of large cell carcinomas of the lung.
    Rossi G; Marchioni A; Milani M; Scotti R; Foroni M; Cesinaro A; Longo L; Migaldi M; Cavazza A
    Am J Clin Pathol; 2004 Dec; 122(6):884-93. PubMed ID: 15595193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spindle cell and pleomorphic ("sarcomatoid") carcinomas of the lung: an immunohistochemical analysis of 86 cases.
    Weissferdt A; Kalhor N; Rodriguez Canales J; Fujimoto J; Wistuba II; Moran CA
    Hum Pathol; 2017 Jan; 59():1-9. PubMed ID: 27569293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. If it's not CK5/6 positive, TTF-1 negative it's not a squamous cell carcinoma of lung.
    Downey P; Cummins R; Moran M; Gulmann C
    APMIS; 2008 Jun; 116(6):526-9. PubMed ID: 18754327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A study of ΔNp63 expression in lung non-small cell carcinomas.
    Nonaka D
    Am J Surg Pathol; 2012 Jun; 36(6):895-9. PubMed ID: 22367298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular dissection of large cell carcinomas of the lung with null immunophenotype.
    Harms A; Endris V; Winter H; Kriegsmann M; Stenzinger A; Schirmacher P; Warth A; Kazdal D
    Pathology; 2018 Aug; 50(5):530-535. PubMed ID: 29958730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytological, histological, and immunohistochemical findings of pulmonary carcinomas with basaloid features.
    Crapanzano JP; Loukeris K; Borczuk AC; Saqi A
    Diagn Cytopathol; 2011 Feb; 39(2):92-100. PubMed ID: 21254456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Large cell carcinoma of lung: On the verge of extinction?
    Weissferdt A
    Semin Diagn Pathol; 2014 Jul; 31(4):278-88. PubMed ID: 25023633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progenitor stem cell marker expression by pulmonary carcinomas.
    Moreira AL; Gonen M; Rekhtman N; Downey RJ
    Mod Pathol; 2010 Jun; 23(6):889-95. PubMed ID: 20305619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Large cell carcinoma of the lung: an endangered species?
    Pardo J; Martinez-Peñuela AM; Sola JJ; Panizo A; Gúrpide A; Martinez-Peñuela JM; Lozano MD
    Appl Immunohistochem Mol Morphol; 2009 Oct; 17(5):383-92. PubMed ID: 19444077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pulmonary neuroendocrine tumors and preneoplasic lesions].
    Rouquette Lassalle I
    Ann Pathol; 2016 Jan; 36(1):34-43. PubMed ID: 26776366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissecting Pulmonary Large-Cell Carcinoma by Targeted Next Generation Sequencing of Several Cancer Genes Pushes Genotypic-Phenotypic Correlations to Emerge.
    Pelosi G; Fabbri A; Papotti M; Rossi G; Cavazza A; Righi L; Tamborini E; Perrone F; Settanni G; Busico A; Testi MA; Maisonneuve P; De Braud F; Garassino M; Valeri B; Sonzogni A; Pastorino U
    J Thorac Oncol; 2015 Nov; 10(11):1560-9. PubMed ID: 26317919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The diagnostic value of TTF-1, CK 5/6, and p63 immunostaining in classification of lung carcinomas.
    Kargi A; Gurel D; Tuna B
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):415-20. PubMed ID: 18091384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Close relation of large cell carcinoma to adenocarcinoma by hierarchical cluster analysis: implications for histologic typing of lung cancer on biopsies.
    Hammer SH; Prall F
    Appl Immunohistochem Mol Morphol; 2015 Sep; 23(8):550-7. PubMed ID: 25789531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas.
    Lyda MH; Weiss LM
    Hum Pathol; 2000 Aug; 31(8):980-7. PubMed ID: 10987260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.